Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;86:1031-1037

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Methods
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katayama, T.
Right arrow Articles by Suematsu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katayama, T.
Right arrow Articles by Suematsu, M.
Related Collections
Right arrow Imaging
Right arrow Peripheral vascular disease
Right arrow Antiplatelets
Right arrow Platelets
Right arrow Other Vascular biology
(Circulation Research. 2000;86:1031.)
© 2000 American Heart Association, Inc.


Molecular Medicine

Immunoneutralization of Glycoprotein Ib{alpha} Attenuates Endotoxin-Induced Interactions of Platelets and Leukocytes With Rat Venular Endothelium In Vivo

Tomihiro Katayama, Yasuo Ikeda, Makoto Handa, Takuya Tamatani, Shinji Sakamoto, Masaharu Ito, Yuzuru Ishimura, Makoto Suematsu

From the Departments of Biochemistry (Y. Ishimura, M.S.) and Medicine (Y. Ikeda) and Blood Center (M.H.), School of Medicine, Keio University, Tokyo; the Department of Obstetrics and Gynecology, Ehime University School of Medicine, Ehime (T.K., M.I.); and the Pharmaceutical Frontier Research Laboratories, JT Inc, Yokohama, Kanagawa (T.T., S.S.), Japan.

Correspondence to Makoto Suematsu, MD, PhD, Associate Professor, Department of Biochemistry, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail msuem{at}mc.med.keio.ac.jp


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—This study aimed to examine molecular mechanisms for endotoxin-induced adhesive changes in platelets in vivo. Platelets labeled with carboxyfluorescein diacetate succinimidyl ester were visualized in rat mesenteric venules through intravital microscopy assisted by a high-speed fluorescence video imager at 1000 frames per second or by a normal-speed intensifier under monitoring of erythrocyte velocity. Leukocyte rolling was examined by normal-speed transmission video images. The velocity of platelets traveling along the centerline of venules followed that of erythrocytes, whereas that measured at the periendothelial space was significantly smaller than the erythrocyte velocity; a majority of these cells exhibited transient but notable rolling with endothelium. Administration of endotoxin increased the density of periendothelial platelets and reduced the rolling velocities of platelets and leukocytes in venules: All events were attenuated by anti–rat P-selectin monoclonal antibody s789G or by anti–human glycoprotein (GP) Ib{alpha} monoclonal antibody GUR83/35, which blocks ristocetin-induced aggregation of rat platelets. Isolated rat platelets injected into endotoxin-pretreated rats were able to roll on the venules. This event was attenuated by pretreatment of platelets in vitro with GUR83/35 but not with s789G, suggesting involvement of endothelial P-selectin and platelet GP Ib{alpha} in the endotoxin-induced responses. Furthermore, isolated human platelets showed similar rolling interactions with endotoxin-preexposed rat venules, and pretreatment of the platelets with GUR83/35, but not with s789G, significantly reduced such interactions. Our results provide the first evidence for involvement of GP Ib{alpha} in endotoxin-induced microvascular rolling of platelets and leukocytes, and this system serves as a potentially useful tool to examine GP Ib{alpha}–associated function of human platelets in vivo.


Key Words: platelets • endothelial cells • P-selectin • shear stress • endotoxin


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Under physiological conditions, platelets are thought to circulate in close contact with microvascular endothelial cells without adhering to their surface. The cells have been thought to neither adhere to the site of injury nor undergo activation until these cells are exposed to platelet-activating subendothelial substances such as collagen.1 On the initial adhesive process, platelets can release varied mediators and activate other platelets.2 Once the first layer of adhered platelets forms the stable thrombogenic surface, growth of the hemostatic plug occurs dependently on the mediator-elicited platelet-to-platelet interactions.2 These 2 events represent adhesion and aggregation of platelets, respectively.

Detailed knowledge of the density or velocity distribution of platelets flowing along the periendothelial space in vivo could help us understand mechanisms for the initial process of thrombogenesis and subsequent inflammatory responses involving leukocyte adhesion for several aspects: First, determination of the density of platelets in the local area allows us to estimate the rate of local platelet delivery. Second, analyses of velocity distribution of the periendothelial platelets make it possible to estimate alterations in adhesive force between platelets and endothelial cells under disease conditions and thus provide important information on changes in their adhesivity under flow conditions. Third, considering the presence of varied adhesion molecules on platelets that might bind to ligand molecules on the surface of leukocytes, the density of platelets in the periendothelial space could determine venular leukocyte recruitment in acute inflammatory processes.3 4 However, little knowledge of the behavior of individual platelets circulating close to the periendothelial space has been available because of technical difficulties in visualizing these cells in a reliable manner. We applied intravital ultrahigh-speed intensified microscopy assisted by carboxyfluorescein diacetate succinimidyl ester, a fluorochrome that can stain platelets intravitally. The present results provide evidence that under disease conditions such as endotoxemia, circulating platelets display the periendothelial rolling in postcapillary venules through mechanisms involving endothelial P-selectin and glycoprotein (GP) Ib{alpha} on platelets and help leukocyte rolling and adhesion in vivo.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Our study protocol was approved by the Animal Care and Utilization Committee of Keio University School of Medicine. Male Wistar rats were anesthetized for intravital microscopy of mesenteric microvessels in vivo5 6 7 8 and treated with an intravenous injection of carboxyfluorescein diacetate succinimidyl ester, a nonfluorescent precursor taken up into platelets and partly into leukocytes, forming a stable fluorochrome, carboxyfluorescein succinimidyl ester (CFSE), in the cells.5 6 CFSE-labeled platelets were visualized through multifunctional intravital fluorescence microscopy as described previously.5 7 Advantages of the present approach compared with previous methods for platelet visualization are described in the online-only Materials and Methods (see http://www.circresaha.org). Six main protocols were used: Rats in group 1 were intravenously perfused with physiological saline as a vehicle for 30 minutes. In group 2, rats were injected with lipopolysaccharide (LPS, O111B4; 1.0 mg · kg-1 · h-1 IV for 30 minutes) according to the previous experimental model of endotoxemia.9 Animals in groups 3 and 4 were pretreated with new monoclonal antibodies (mAbs) against rat P-selectin s789G and s84F. Rats in groups 5 and 6 were pretreated with anti–human GP Ib{alpha} mAbs, GUR83/35 and WGA3. GUR83/35 is reported to recognize a conformation-specific epitope between residues 1 and 302 of GP Ib{alpha} and to block the binding of von Willebrand factor to human platelets in the presence of ristocetin, whereas WGA3 binds to the same region but does not block the ristocetin-induced aggregation of platelets.10 11 These mAbs were injected at 1.5 mg/kg IV 5 minutes before the start of the LPS infusion. Individual erythrocytes and platelets were visualized through an ultrahigh-speed intensified video microscope. This system allowed us to visualize platelets and erythrocytes at 1000 frames per second for 1 second under epi-illumination and transillumination, respectively. Velocities of individual platelets were normalized by dividing the values by the regional erythrocyte velocity in the centerline or the periendothelial region, with the result designated as the relative platelet velocity (VP/VR) in each region. This value serves as a semiquantitative index of the adhesion energy between platelets and endothelial cells. We examined differences in circulating platelet counts and the density of platelets between the periendothelial and centerline regions of microvessels as shown in previous studies using acridine red–assisted intravital microscopy.12 The normalized densities of CFSE-positive platelets in the centerline (DPC) and periendothelial (DPE) regions were defined as described in the online-only Materials and Methods (see http://www.circresaha.org). The relative rolling velocity of leukocytes (VW/VR) and the density of adherent cells were determined separately with normal-speed transmission video images as described elsewhere.5 7 In other experiments, isolated rat and human platelets were injected intravenously into rats undergoing 30-minute exposure to the LPS infusion, and their behavior in venules was examined with a silicon-intensified target (SIT) camera.8 Function of isolated platelets was examined with a laser-scattering platelet aggregometer. Anti–P-selectin mAbs were generated, and their ability to block P-selectin–mediated cell adhesion in vitro was characterized. Differences among groups were examined by 1-way ANOVA with Fisher’s multiple comparison test.

An expanded Materials and Methods section is available online at http://www.circresaha.org.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Individual Platelets Labeled With CFSE
Figure 1Down illustrates the effects of in vivo fluorescence labeling with CFSE on platelet aggregation. As seen in Figures 1ADown and 1BDown, the distribution of rat platelets on a culture dish corresponded to that of the cells tagged with fluorescence, whereas not all platelets were able to be visualized under the same optical conditions as used for intravital microscopy. As depicted in Figure 1CDown, platelets labeled or unlabeled with CFSE were equally activated and displayed similar extents of microaggregate formation in response to ristocetin and ADP. Peak signal intensities indicating small and large aggregates and peak percentage values of light transmission (%T) elicited by ADP were not statistically different between the groups (Table 1Down). Furthermore, time to observe these peak values did not differ significantly. Circulating counts of platelets were not different between the animals treated or untreated with CFSE (data not shown). Collectively, the present method for labeling of platelets allowed us to observe individual platelets through fluorescence microscopy without notable alterations in platelet functions in vitro.



View larger version (71K):
[in this window]
[in a new window]
 
Figure 1. Representative pictures showing individual platelets labeled with CFSE in vivo. A and B, Representative phase-contrast transillumination image and the corresponding fluorograph of the platelet-rich suspension. Bar=25 µm. C, Effects of labeling with CFSE on stimulus-dependent formation of microaggregates. Data collected from the CFSE-untreated [CFSE(-)] and CFSE-treated [CFSE(+)] platelets, respectively. Arrows in these panels show time of the application of ristocetin or ADP. s and l indicate time history of small and large microaggregate formation, respectively.


View this table:
[in this window]
[in a new window]
 
Table 1. Effects of In Vivo CFSE Labeling on ADP-Induced Platelet Aggregation In Vitro

Millisecond Interactions of Platelets With Microvascular Endothelium
As shown in Figure 2ADown, videorecording at 1000 frames per second under transillumination allowed us to visualize individual erythrocytes packed in microvessels and recognized as granular patterns of images. Regional velocities of single erythrocytes in venules were analyzed by tracing movement of each cell per unit frame with a frame-by-frame analysis, as shown in Figure 3Down. At this recording rate, CFSE-labeled platelets can be visualized, but their exact localization inside the vessels could hardly be identified because of their rapidity of movement, as seen in Figure 2BDown. Conversely, their frame-by-frame reproduction by replaying at 30 frames per second allowed us to visualize individual platelets as pinpoint dots and to trace movement of these cells along vessel walls. As seen in serial fluorographs with 20- or 40-ms intervals in Figures 2CDown through 2H, a single platelet moving in the periendothelial space of the venule exhibited quite heterogeneous changes in its velocity. The distance of movement per unit time in 1 cell (arrows) differed greatly from that in another cell (asterisks), indicating a heterogeneity in velocities among different platelets.



View larger version (149K):
[in this window]
[in a new window]
 
Figure 2. Sequential microfluorographs showing intravital behavior of platelets labeled with CFSE captured by ultrahigh-speed video microscopy. A, Representative transillumination image captured at 1000 frames per second. Bar=30 µm. a indicates arteriole; v, venule. B, Microfluorograph captured at 30 frames per second in the same vessels. C through H, Series of microfluorographs captured every 20 to 40 ms in the same region. Asterisks and vertical arrows indicate serial changes in positions of 2 platelets interacting with the venular wall. Horizontal arrows denote direction of blood flow in each vessel.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 3. Spatial and temporal profiles of velocities of erythrocytes and platelets in the rat mesenteric venules. A, Representative data of erythrocyte velocities determined at a venule of the LPS-untreated control. Mean values of 5 measurements in the same site were plotted as a function of time and domain in the single vessel observed. The value 100 indicates the maximum erythrocyte velocity measured at the centerline region. Pc and Pe denote centerline and periendothelial regions of the microvessels, respectively. B, Representative behavior of individual platelets running through centerline and periendothelial regions of the LPS-untreated control venule. C, Histogram analyses of VP/VR in the vehicle- and LPS-treated venules. Data were collected from {approx}100 different platelets in individual experiments using >6 rats in each group.

Spatial and Temporal Alterations in Erythrocyte Velocity in Microvessels
On the basis of the frame-by-frame analysis of transillumination images, we examined temporal and spatial profiles of the erythrocyte velocity in postcapillary venules. As seen in Figure 3AUp, showing the velocity of single erythrocytes (z axis) as a function of time (x axis) and position (y axis) of measurements, the velocity measured in the venular centerline region did not fluctuate greatly. The velocity of erythrocytes flowing in venules was greater in the centerline region than in the periendothelial region. This observation led us to hypothesize that the heterogeneity of movement of platelets in the periendothelial region illustrated in Figure 2Up could result from transient adhesive interactions of the cells with the endothelial surface rather than from local changes in erythrocyte velocities. To test this hypothesis, we examined alterations in the relative velocity of individual platelets versus erythrocyte velocity (VP/VR) in venules of the control rats. As shown in 3B, the VP/VR values of a single platelet flowing at the centerline of venules was almost constant, at {approx}100%, in venules. Conversely, the velocity of platelets flowing in the periendothelial regions exhibited a fluctuating pattern: The VP/VR values of these platelets occasionally became as low as 50% of the local erythrocyte velocity, suggesting the presence of adhesive interactions between the periendothelial platelets and microvascular endothelium.

Such a baseline level of the platelet-endothelium interactions was enhanced by treatment of rats with LPS. Figure 3CUp illustrated histograms showing distribution of the VP/VR values in the periendothelial space of venules. In the controls, the periendothelial platelet velocity varied greatly among different cells, whereas the mean VP value was {approx}92% of the mean VR value, and {approx}50% of the cells exhibited a velocity <90% of the regional erythrocyte velocity. At 30 minutes after the start of the LPS administration, venular wall shear rates did not change significantly, but the VP/VR histogram exhibited a marked shift to the left side. Under the present experimental conditions, venular wall shear rates in the LPS-untreated and -treated rats were 486±39 s-1 and 476±52 s-1 (mean±SD of 7 experiments), respectively, showing no statistical difference. These results suggest that LPS increases the adhesion energy between periendothelial platelets and venular endothelium in vivo.

P-Selectin–Mediated Microvascular Rolling of Platelets in LPS-Treated Rats
We determined the effects of mAbs against P-selectin and GP Ib{alpha} and then applied them to the in vivo systems. Figure 4ADown illustrates the effects of the anti–rat P-selectin mAbs on the intercellular adhesion between the P-selectin–expressing transfectant and HL-60 cells. The mAb s789G, but not s84F, dose-dependently attenuated the cell adhesion, indicating that the former mAb serves as a reagent to block leukocyte adhesion. Figure 4BDown depicted effects of anti–human GP Ib{alpha} mAbs on ristocetin-induced aggregation of rat platelets. As seen, GUR83/35, but not WGA3, significantly suppressed ristocetin-induced responses of rat cells, indicating that the former mAb can be used to block the rat GP Ib{alpha}–mediated events.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 4. Effects of mAbs against P-selectin and GP Ib{alpha} on the LPS-induced changes in the density and velocity of platelets traveling at the periendothelial space. A, Effects of anti–P-selectin mAbs s789G and s84F on adhesion of HL60 cells to the P-selectin–overexpressing CHO cells in culture. B, Effects of the anti–GP Ib{alpha} mAb GUR83/35 and WGA3 on ristocetin-induced aggregation of rat platelets. *P<0.05 vs untreated controls; {dagger}P<0.05 vs data in the WGA3-treated platelets. C, Inhibitory effects of these mAbs on LPS-induced changes in the circulating number of platelets (PLT), DPE/DPC, and VP/VR. *P<0.05 vs control values. The values indicate mean+SEM of 6 different rats in all groups. {dagger}P<0.05 vs group treated with s789G; #P<0.05 vs group treated with GUR83/35.

Figure 4CUp shows LPS-induced alterations in circulating platelet counts and density (DPE/DPC) and velocity (VP/VR) of periendothelial platelets in venules and depicts the effects of the aforementioned mAbs against P-selectin or GP Ib{alpha} on these parameters. Administration of LPS significantly reduced the number of platelets in peripheral blood samples. Conversely, the DPE/DPC values exhibited an {approx}20% elevation on the administration of LPS. The LPS-induced elevation of the periendothelial platelet density coincided with a marked reduction of the mean VP/VR values, indicating an increasing adhesivity between the platelets and endothelial cells. Collectively, the LPS-induced thrombocytopenic changes appeared to occur concurrently with margination of circulating platelets to the periendothelial space. Pretreatment with s789G but not with s84F significantly attenuated the LPS-induced changes in these platelet parameters, suggesting that P-selectin mediates the LPS-induced microvascular margination of platelets. Most importantly, pretreatment with the mAb GUR83/35 but not with WGA3 elicited similar inhibitory effects on the LPS-induced changes, suggesting that functional blockade of GP Ib{alpha} on circulating platelets cancels platelet-endothelium interactions in LPS-exposed venules. Conversely, the administration of 1 of the 2 mAbs to the LPS-untreated rats did not evoke alterations in these parameters (data not shown).

Another important event observed during the administration of LPS was a reduction of the rolling velocity of leukocytes in venules. As seen in Table 2Down, the administration of LPS induced an {approx}60% reduction of the VW/VR. Pretreatment with s789G abolished the LPS-elicited alterations, suggesting involvement of P-selectin in leukocyte rolling in the stimulated venules, which was in good agreement with previous studies.3 8 The LPS-elicited reduction of the rolling velocity was also attenuated significantly by pretreatment with GUR83/35, suggesting that functional blockade of GP Ib{alpha} attenuates the LPS-induced elevation of adhesion energy. The LPS infusion also elicited a marked increase in the density of adherent leukocytes that was attenuated by pretreatment with s789G. The blockade of GP Ib{alpha} by GUR83/35 also attenuated the LPS-induced venular leukocyte adhesion significantly, although its effect was smaller than that of s789G. Collectively, these results suggest that the platelet adhesion molecule GP Ib{alpha} is a determinant involved in mechanisms for the LPS-induced microvascular leukocyte recruitment.


View this table:
[in this window]
[in a new window]
 
Table 2. Effects of Administration of Anti–P-selectin mAb s789G and Anti–GP Ib{alpha} mAb GUR83/35 on LPS-Induced Alternations in Rolling Velocity and Adherence of Leukocytes in Venules

Role of GP Ib{alpha} in Rolling of Rat and Human Platelets in LPS-Pretreated Venules
Observations shown in Figure 4Up led us to further examine the roles of P-selectin and GP Ib{alpha} in the LPS-induced interactions between platelets and venular endothelium. To that effect, differences in adhesivity of isolated rat platelets pretreated or not treated with mAbs against these adhesion molecules were examined in LPS-pretreated rats under observation with an SIT camera. Once injected, the platelets displayed a transient adhesion and rolling, and some cells exhibited stationary adhesion to the venular endothelium (Figure 5Down). A subpopulation of the platelets flowing at the periendothelial space often attached to rolling leukocytes and made them slow down further. Formation of leukocyte-platelet complex was seen occasionally. As summarized in Figure 5Down, right, CFSE-labeled platelet rolling on venules was enhanced by pretreatment with LPS. When the isolated platelets were pretreated with the mAb s789G, their adhesive responses were not greatly changed. By contrast, pretreatment of the isolated platelets with GUR83/35 almost abolished their adhesion to the LPS-preexposed venules. These results showed that blockade of constitutively expressed GP Ib{alpha} on platelets is involved in mechanisms through which this mAb administered in vivo attenuated the LPS-induced platelet interactions with the endothelium.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 5. Representative pictures showing microvascular behavior of exogenously injected CFSE-labeled rat platelets in LPS-exposed mesenteric venules and effects of immunoneutralization of GP Ib{alpha} on their density. Numbers at top left corner of each picture show time after beginning of injection of CFSE-labeled platelets. White and black asterisks denote platelets showing rolling and capturing of platelets, respectively. White arrow indicates fluorescent platelets adhered to the surface of a rolling leukocyte. Black arrows show a leukocyte undergoing collision with a free-flowing platelet, forming a complex and slowing down to become adhered to the venular wall. Bar=40 µm. Right, Effects of in vitro pretreatment with s789G or GUR83/35 on the number of CFSE-labeled platelets (PLT) rolling on the LPS-preexposed venules. *P<0.05 vs data collected from LPS-untreated controls; {dagger}P<0.05 vs data from LPS-treated rats. The data indicate mean+SEM of 4 to 5 separate experiments.

This observation tempted us to examine whether human platelets could utilize GP Ib{alpha}–mediated mechanisms to adhere to rat venular endothelium in vivo. As seen in Figure 6ADown, the platelets administered into the LPS-treated rats exhibited rolling with greater frequency than those administered into the untreated controls over the whole ranges of the velocities. The population of the slow rollers with velocities <0.2 mm/s became markedly elevated in the LPS-treated group. As shown in Figure 6BDown, in vitro pretreatment of human platelets with the mAb GUR83/35, but not with WGA3, significantly attenuated such adhesive changes observed in vivo. Thus, the present findings demonstrated that human platelets exogenously administered into the rat vascular system are able to roll on microvascular endothelium through GP Ib{alpha}–mediated mechanisms.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 6. Rolling behavior of CFSE-labeled human platelets in vivo. A, Histogram analyses showing the number of the rolling platelets as a function of the rolling velocity (VP) in rats pretreated with vehicle or LPS. B, Effects of in vitro pretreatment with mAbs against GP Ib{alpha} on rolling of human platelets to the LPS-preexposed venules. GUR83/35 is the function-blocking mAb, whereas WGA3 is the nonblocking mAb. *P<0.05 vs data collected from vehicle-treated rats; {dagger}P<0.05 vs data from LPS-treated rats. Data indicate mean+SEM of 5 separate experiments.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
High-speed microfluorography allowed us to show that platelets not only can traverse through the centerline region of microvessels in a free-flowing manner but also can move along the periendothelial region and display notable interactions with the endothelial surface at millisecond intervals even under unstimulated, ordinary conditions. Such interactions of platelets are distinct from the slow rolling behavior observed only in a subpopulation of platelets that has been detected by normal-speed videomicroscopy.13 14 Although this varied among individual cells, a majority of periendothelial platelets displayed rapid but detectable attachment to the endothelium, and some of them exhibited a velocity <50% of the erythrocyte velocity measured in situ. Such interactions of platelets were markedly enhanced by LPS treatment. The present data indicate that unstimulated platelets are able to roll on the LPS-preexposed venules and suggest a crucial role of P-selectin expressed at the side of the stimulated endothelium, as also shown in previous reports using different experimental models.14 15 Moreover, this adhesion molecule appears to be involved in the LPS-induced shift of platelet distribution toward the periendothelial space. However, we were unable to address molecular determinants for the baseline adhesive interactions of platelets with the unstimulated venules: Inasmuch as the s789G pretreatment did not alter the baseline platelet interactions in vivo, the role of P-selectin in vivo appeared to be small or none.

Most importantly, the present study provided a novel insight into mechanisms for platelet adhesion mediated by GP Ib{alpha} in vivo. Two parameters were significantly altered by LPS through mechanisms involving GP Ib{alpha}: increases in the adhesion energy of platelets to venular endothelium and the density of the cells traveling along the periendothelial space. Because 1 of the mAbs s789G and GUR83/35 at the present dose sufficiently attenuated the LPS-induced changes in these platelet parameters, the interaction between P-selectin expressed on the LPS-stimulated venular endothelium and GP Ib{alpha} on platelets appears to play a role in the adhesive responses of platelets. This notion is fully supported by recent studies in vitro showing that GP Ib{alpha} serves as a platelet counterreceptor for P-selectin.16

Another important event observed under GP Ib{alpha} immunoneutralization is downregulation of LPS-induced venular leukocyte rolling and adhesion: Several different patterns of platelet-leukocyte interactions were observed in the LPS-treated microvessels. First, as also shown elsewhere,3 17 circulating platelets adhere to the surface of leukocytes and thereby help them slow down to roll and adhere. Second, platelets moving along the periendothelial space may by chance collide with leukocytes rolling directly along venular endothelium and help them slow down further for stationary adhesion. The GP Ib{alpha}–mediated elevation of the periendothelial platelet density and increase in the adhesion energy to the LPS-exposed venules could enhance both of these mechanisms for intercellular interactions and secondarily activate leukocyte adhesivity. Detailed molecular mechanisms for the GP Ib{alpha}–mediated direct interactions between platelets and leukocytes in vivo (eg, L-selectin) and involvement of plasma factors reacting with GP Ib (eg, von Willebrand factor) should be examined further.18 19

Finally, our study revealed that the rat system serves as a potentially useful tool to examine GP Ib{alpha}–associated function of human platelets in vivo, in that they can utilize GP Ib{alpha} to roll in a manner similar to that of rat platelets on the stimulated microvascular endothelial cells. GP Ib has been known to play important roles in a variety of functional alterations of platelets in vitro, such as shear-dependent aggregation19 and adhesion to immobilized von Willebrand factor under flow conditions in vitro.20 In humans, conversely, there are genetic disorders of this adhesion molecule, such as Bernard-Soulier syndrome21 or cases of heightened platelet aggregation by ristocetin.10 22 However, a pathophysiological link of such in vitro events to actual behavior of functionally impaired platelets in vivo is largely unknown because of lack of the intravital system to examine human platelet functions. Determination of impaired adhesive properties of human platelets collected from disease patients deserves further studies to understand the whole mechanisms for platelet-dependent hemostatic and thrombotic disorders from microvascular viewpoints, and such studies are under way in our laboratories.


*    Acknowledgments
 
This work was supported by Advanced Medical Technology in Health Sciences Research Grants from Ministry of Health and Welfare and in part by Keio Medical Science Fund.

Received January 31, 2000; accepted March 29, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Curwen KD, Gimbrone MA Jr, Handin RI. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells. Lab Invest. 1980;42:366–374.[Medline] [Order article via Infotrieve]

2. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost. 1997;78:611–616.[Medline] [Order article via Infotrieve]

3. Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 1994;71:380–386.[Medline] [Order article via Infotrieve]

4. Diacovo TG, Catalina MD, Siegelman MH, von Andrian UH. Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. J Exp Med. 1998;187:197–204.[Abstract/Free Full Text]

5. Suematsu M, Suzuki H, Tamatani T, Iigou Y, DeLano FA, Miyasaka M, Forrest MJ, Kannagi R, Zweifach BW, Ishimura Y, et al. Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats. J Clin Invest. 1995;96:2009–2016.

6. Suematsu M, DeLano FA, Poole D, Engler RL, Miyasaka M, Zweifach BW, Schmid-Schönbein GW. Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation. Lab Invest. 1994;70:684–695.[Medline] [Order article via Infotrieve]

7. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Ishimura Y, Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res. 1999;85:663–671.[Abstract/Free Full Text]

8. Suematsu M, Goda N, Sano T, Kashiwagi S, Egawa T, Shinoda Y, Ishimura Y. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest. 1995;96:2431–2437.

9. Schoendorf TH, Rosenberg M, Beller FK. Endotoxin-induced disseminated intravascular coagulation in nonpregnant rats: a new experimental model. Am J Pathol. 1971;65:51–58.[Medline] [Order article via Infotrieve]

10. Moriki T, Murata M, Kitaguchi T, Anbo H, Handa M, Watanabe K, Takahashi H, Ikeda Y. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239->Val) reported in patients with platelet-type von Willebrand disease. Blood. 1997;90:698–705.[Abstract/Free Full Text]

11. Asazuma N, Ozaki Y, Satoh K, Yatomi Y, Handa M, Fujimura Y, Miura S, Kume S. Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets. Blood. 1997;90:4789–4798.[Abstract/Free Full Text]

12. Woldhuis B, Tangelder GJ, Slaaf DW, Reneman RS. Concentration profile of blood platelets differs in arterioles and venules. Am J Physiol. 1992;262:H1217–H1223.[Abstract/Free Full Text]

13. Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD. Platelet-endothelial interactions in inflamed mesenteric venules. Blood. 1998;91:1318–1324.[Abstract/Free Full Text]

14. Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, Messmer K. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood. 1998;92:507–515.[Abstract/Free Full Text]

15. Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A. 1995;92:7450–7454.[Abstract/Free Full Text]

16. Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P- selectin. J Exp Med. 1999;190:803–814.[Abstract/Free Full Text]

17. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 1996;94:1239–1246.[Abstract/Free Full Text]

18. Theilmeier G, Lenaerts T, Remacle C, Collen D, Vermylen J, Hoylaerts MF. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood. 1999;94:2725–2734.[Abstract/Free Full Text]

19. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234–1240.

20. Marchese P, Saldivar E, Ware J, Ruggeri ZM. Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field. Proc Natl Acad Sci U S A. 1999;96:7837–7842.[Abstract/Free Full Text]

21. Berndt MC, Gregory C, Chong BH, Zola H, Castaldi PA. Additional glycoprotein defects in Bernard-Soulier’s syndrome: confirmation of genetic basis by parental analysis. Blood. 1983;62:800–807.[Abstract/Free Full Text]

22. Takahashi H, Murata M, Moriki T, Anbo H, Furukawa T, Nikkuni K, Shibata A, Handa M, Kawai Y, Watanabe K, et al. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease. Blood. 1995;85:727–733.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. N. Patel, S. H. Soubra, R. V. Bellera, J.-F. Dong, C. A. McMullen, A. R. Burns, and R. E. Rumbaut
Differential Role of von Willebrand Factor and P-Selectin on Microvascular Thrombosis in Endotoxemia
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2225 - 2230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. He, H. Zhang, L. Zhu, Y. Jiang, and X. Zhou
Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H591 - H599.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A.-l. Stahl, M. Svensson, M. Morgelin, C. Svanborg, P. I. Tarr, J. C. Mooney, S. L. Watkins, R. Johnson, and D. Karpman
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome
Blood, July 1, 2006; 108(1): 167 - 176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Miyao, Y. Suzuki, K. Takeshita, H. Kudo, M. Ishii, R. Hiraoka, K. Nishio, T. Tamatani, S. Sakamoto, M. Suematsu, et al.
Various adhesion molecules impair microvascular leukocyte kinetics in ventilator-induced lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1059 - L1068.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. C. Pitchford, S. Momi, S. Giannini, L. Casali, D. Spina, C. P. Page, and P. Gresele
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation
Blood, March 1, 2005; 105(5): 2074 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Gotoh, J.-i. Suzuki, H. Kosuge, T. Kakuta, S. Sakamoto, M. Yoshida, and M. Isobe
E-Selectin Blockade Decreases Adventitial Inflammation and Attenuates Intimal Hyperplasia in Rat Carotid Arteries After Balloon Injury
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2063 - 2068.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. C. Wood, R. P. Hebbel, and D. N. Granger
Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1608 - H1614.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
W. C. Aird
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Mayo Clin. Proc., July 1, 2003; 78(7): 869 - 881.
[Abstract] [PDF]


Home page
Hum ReprodHome page
T. Katayama, Y. Kusanagi, M. Kiyomura, H. Ochi, and M. Ito
Leukocyte behaviour and permeability in the rat mesenteric microcirculation following induction of ovulation
Hum. Reprod., June 1, 2003; 18(6): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. C. Aird
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Blood, May 15, 2003; 101(10): 3765 - 3777.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Berndt
Induction of Platelet-Endothelial Interactions in Postcapillary Venules in Hypercholesterolemia: Critical Role of P-Selectin
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 525 - 527.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. H. Cerwinka, D. Cooper, C. F. Krieglstein, C. R. Ross, J. M. McCord, and D. N. Granger
Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H535 - H541.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Russell, D. Cooper, A. Tailor, K. Y. Stokes, and D. N. Granger
Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets
Am J Physiol Gastrointest Liver Physiol, January 1, 2003; 284(1): G123 - G129.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
T. E. Warkentin, W. C. Aird, and J. H. Rand
Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome
Hematology, January 1, 2003; 2003(1): 497 - 519.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Kashiwagi, M. Kajimura, Y. Yoshimura, and M. Suematsu
Nonendothelial Source of Nitric Oxide in Arterioles But Not in Venules: Alternative Source Revealed In Vivo by Diaminofluorescein Microfluorography
Circ. Res., December 13, 2002; 91 (12): e55 - e64.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. H. Cerwinka, D. Cooper, C. F. Krieglstein, M. Feelisch, and D. N. Granger
Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1111 - H1117.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Shen, J.-f. Dong, G. M. Romo, W. Arceneaux, A. Aprico, E. E. Gardiner, J. A. Lopez, M. C. Berndt, and R. K. Andrews
Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ibalpha using canine-human chimeras
Blood, January 1, 2002; 99(1): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Nishijima, J. Kiryu, A. Tsujikawa, M. Honjo, A. Nonaka, K. Yamashiro, H. Tanihara, S. J. Tojo, Y. Ogura, and Y. Honda
In Vivo Evaluation of Platelet-Endothelial Interactions after Transient Retinal Ischemia
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2102 - 2109.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Methods
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katayama, T.
Right arrow Articles by Suematsu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katayama, T.
Right arrow Articles by Suematsu, M.
Related Collections
Right arrow Imaging
Right arrow Peripheral vascular disease
Right arrow Antiplatelets
Right arrow Platelets
Right arrow Other Vascular biology